Drug Information

Drug General Information
Drug ID
D0F9KI
Former ID
DIB000335
Drug Name
LAS-30538
Drug Type
Small molecular drug
Indication Hyperinsulinemia [ICD10:E16.1] Terminated [526783]
Company
Almirall Prodesfarma SA
Formula
C28H31F2NO2
Canonical SMILES
C(c1ccc(cc1)F)(c1ccc(cc1)F)(C1CCN(CC1)CCOc1c(cccc1C)C)O
CAS Number
CAS 145067-04-5
PubChem Compound ID
132693
Target and Pathway
Target(s) Calcium channel Target Info Modulator [526783]
References
Ref 526783The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs. J Pharm Pharmacol. 1992 Oct;44(10):851-5.
Ref 526783The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs. J Pharm Pharmacol. 1992 Oct;44(10):851-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.